Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Pathology
|
June 16, 2009
Transcription factor Nfat1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes
Jinxi Wang, Brian M Gardner, Qinghua Lu, et al.
Cancer Research
|
June 13, 2018
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties
Jeff Hirst, Harsh B Pathak, Stephen Hyter, et al.
Plos One
|
January 28, 2009
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation
Shun Liang, Nuo Yang, Yue Pan, et al.
Endocrinology
|
February 11, 2014
Generation of Esr1-knockout rats using zinc finger nuclease-mediated genome editing
M A Karim Rumi, Pramod Dhakal, Kaiyu Kubota, et al.
Cell Death & Disease
|
May 25, 2024
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer
David Standing, Prasad Dandawate, Sumedha Gunewardena, et al.
Cancer Research
|
May 3, 2006
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma
Lin Zhang, Jia Huang, Nuo Yang, et al.
Plos One
|
April 28, 2010
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers
Shan Deng, Xiaojun Yang, Heini Lassus, et al.
Endocrinology
|
May 19, 2017
Defining the Role of Estrogen Receptor β in the Regulation of Female Fertility
M A Karim Rumi, Prabhakar Singh, Katherine F Roby, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2006
Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues
Yu Mi Ahn, Lakshminarayana Vogeti, Chun-Jing Liu, et al.
Gynecologic Oncology
|
April 19, 2021
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer
Vijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Pathology
|
June 16, 2009
Transcription factor Nfat1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes
Jinxi Wang, Brian M Gardner, Qinghua Lu, et al.
Cancer Research
|
June 13, 2018
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties
Jeff Hirst, Harsh B Pathak, Stephen Hyter, et al.
Plos One
|
January 28, 2009
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation
Shun Liang, Nuo Yang, Yue Pan, et al.
Endocrinology
|
February 11, 2014
Generation of Esr1-knockout rats using zinc finger nuclease-mediated genome editing
M A Karim Rumi, Pramod Dhakal, Kaiyu Kubota, et al.
Cell Death & Disease
|
May 25, 2024
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer
David Standing, Prasad Dandawate, Sumedha Gunewardena, et al.
Cancer Research
|
May 3, 2006
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma
Lin Zhang, Jia Huang, Nuo Yang, et al.
Plos One
|
April 28, 2010
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers
Shan Deng, Xiaojun Yang, Heini Lassus, et al.
Endocrinology
|
May 19, 2017
Defining the Role of Estrogen Receptor β in the Regulation of Female Fertility
M A Karim Rumi, Prabhakar Singh, Katherine F Roby, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2006
Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues
Yu Mi Ahn, Lakshminarayana Vogeti, Chun-Jing Liu, et al.
Gynecologic Oncology
|
April 19, 2021
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer
Vijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, et al.
Page
of 6